December 2022
Includes: 2022 Pathfinder Award, Prostatitis and risk of Prostate Cancer, The Standard of Care for Low Risk Prostate Cancer, Delayed Urologic Cancer Care during COVID-19, and more!
November 2022
Includes: Hybrid meeting details, call for participants for new MRU study, 2022 Pathfinder Award recipient revealed, Stress can increase cancer mortality, PTSD in prostate cancer patients, and more!
October 2022
Includes: New meeting space and focus groups for next meeting, The Changing Landscape of Systemic Therapy, How to Read a Genomic Testing Report, Prognosis of prostate cancer patients improved, and more!
September 2022
Includes: Return to Face-to-Face meetings at Grey Eagle, Entering a New Era of Robotic Surgery, Understanding the Mechanisms of Exercise as Medicine to Increase Prostate Cancer Survival, and more!
August 2022
Includes: 50/50 Fundraising Raffle, Transforming Cancer Treatment with a Tablespoon of Blood, Best Prostate Biopsy Techniques in 2022, Prostate Cancer Virtual Conference, and more!
July 2022
Includes: PROSTAID 50/50 Fundraising Raffle, Membership Door Prize Winner Announced, iSTRIDE Research Study, Treatment of the Primary or Local Relapse in nmCRPC, CADTH Study Participants Needed, and more!
June 2022
Includes: Guest Speaker Bob Molle bio, Remembering Stewart Campbell, AGM Door Prize, Relationship between PSA and Testosterone levels in Men, Impact of Next Generation Imaging, Patients with metastatic prostate cancer living significantly longer, Canadian Cancer Survivor Network survey, and more!
May 2022
Includes: Dr. Linda Carlson bio, Are We Making Progress in Addressing Disparities in Prostate Cancer?, Treatment-Related Regret Among Men With Localized Prostate Cancer Journal Club, Seniors’ Centre Without Walls Edmonton, PCRI 2022 videos, and more!
April 2022
Includes: Demystifying Chronic Pelvic Pain Syndrome, Safa Rahman bio, First-in-Class Radioligand Therapy Approved for Advanced Prostate Cancer, Quality of life between choosing open vs. robotic radical prostatectomy, Cancer Treatment Decisions Survey, and more!
March 2022
Includes: The PREVENT Study, Dr. Philip Barber bio, our first OPEN MIC NIGHT, PROpel Suggests Adding Olaparib to Abi-raterone Improves Outcomes, Risk vs. Benefit for Active Surveillance for Patients with Intermediate-Risk Disease, and more!